Arsenic Toxicity: Molecular Targets and Therapeutic AgentsValeria Marina Nurchi(University of Cagliari), Jan Aaseth(Innlandet Hospital Trust)BiomoleculesFebruary 4, 202010.3390/biom10020235Cited by 249SaveCiteExport RISWatch citationsRelated PapersCerebral Iron Deposition in Neurodegeneration|Biomolecules|2022|149Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens|PLoS ONE|2015|102Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly|PLoS ONE|2018|102Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation|BioMetals|2016|73Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial|PLoS ONE|2015|58